Evoke Pharma Inc
Develops and commercializes a nasal spray for diabetic gastroparesis symptom relief.
EVOK | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 420 STEVENS AVENUE, 92075 SOLANA BEACH
- Website:
- https://evokepharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Evoke Pharma Inc. is a specialty pharmaceutical company focused on developing and commercializing treatments for gastrointestinal (GI) diseases. The company's primary focus is addressing the unmet medical needs of patients with diabetic gastroparesis, a debilitating condition characterized by delayed gastric emptying that can lead to erratic absorption of oral medications. Its commercial product, GIMOTI®, is a nasal spray formulation of metoclopramide for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. This novel delivery system is designed to provide a more reliable absorption route by bypassing the compromised GI tract. Founded in 2007, Evoke is committed to improving patient outcomes through innovative therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all Evoke Pharma Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evoke Pharma Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evoke Pharma Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
